Antidigoxin antibodies neutralize the effect of newborn endogenous digitalis-like factor on erythrocyte 86Rb uptake.
Increasing evidence indicates the existence of endogenous digitalis like factor(s) (EDLF). We recently reported on the partial purification of an EDLF from newborn (cord) blood which possesses both digoxin-like immunoreactivity and the ability to inhibit the cell membrane sodium pump measured as the inhibitory activity on erythrocyte 86Rb uptake. We here report that high affinity digoxin-binding antibodies (Fab fragments; Digibind, Burroughs Wellcome Co.) are capable of neutralizing the inhibitory activity on erythrocyte Rb uptake not only of digoxin but also of ouabain and of partially purified newborn EDLF. These results provide, to our knowledge for the first time, direct evidence that antidigitalis antibodies may cross-react with one or more circulating substances which share antigenic determinants with digoxin and ouabain and possess endogenous digitalis-like properties, strongly suggesting that these antibodies may be useful tools both for the assay of EDLF and for the study of its biological effects.
Balzan
S
S
CNR Institute of Clinical Physiology, University of Pisa, Italy.
Montali
U
U
Biver
P
P
Ghione
S
S
D000906:Antibodies; D001798:Blood Proteins / Q000037:antagonists & inhibitors*; D002298:Cardenolides; D004077:Digoxin / Q000276:immunology*; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D012414:Rubidium Radioisotopes / Q000378:metabolism*; D012503:Saponins; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*
D000906:Antibodies; D001798:Blood Proteins; D002298:Cardenolides; D012414:Rubidium Radioisotopes; D012503:Saponins; C034504:digoxin-like factors; D004077:Digoxin; D000254:Sodium-Potassium-Exchanging ATPase